Methotrexate
Top View
- Prophylaxis Guidelines for the Adult Hematology Patient
- Cyclophosphamide (IV)-Fluorouracil-Methotrexate (CMF
- CMF: Cyclophosphamide, Methotrexate and Fluorouracil
- Chemotherapy Extravasation Management
- Subcutaneous Administration of Anticancer Agents
- Methotrexate Class:Antimetabolite (Antifolate) Indications : Acute
- Antifolate Pseudo-Resistance Due to Elevated Levels of Thymidine and Hypoxanthine in a Commercial Serum Preparation
- Methotrexate 25Mg/Ml Solution for Injection - Summary of Product Characteristics (SPC) - (Emc)
- PATIENT FACT SHEET (Rheumatrex, Trexall, Otrexup, Rasuvo)
- CELEBREX Safely and Effectively
- CELEBREX (Sell-E-Brecks) Celecoxib (Sell-E-Cox-Ib) Consumer Medicine Information
- Pyrimidine-Based Antifolate That Inhibits Multiple Folate-Requiring Enzymes
- Preoperative Guidelines for Medications Prior to Surgery
- Methotrexate and Pregnancy
- Improved Bioavailability and High Photostability of Methotrexate by Spray-Dried Surface-Attached Solid Dispersion with an Aqueous Medium
- Simultaneous Inhibition of Protein Kinase CK2 and Dihydrofolate
- Initial Protocol
- Mtor Inhibitors: a Novel Class of Anti-Cancer Agents Haris Riaz1,2, Talha Riaz1 and Syed a Hussain3*